FDA extends GM salmon consultation

The US Food and Drug Administration (FDA) is extending for 60 days the comment period for the draft Environmental Assessment and preliminary Finding of No Significant Impact linked to AquaBounty Technologies’ application for its genetically modified AquAdvantage salmon. Originally slated to end on Feb. 25, 2013, the comment period now runs until April 26, 2013. Read more here